课题基金 / 基金详情

ORAL DOSAGE FORMS OF ANTI-AIDS AGENTS

ORAL DOSAGE FORMS OF ANTI-AIDS AGENTS
抗艾滋病药物的口服剂型
批准号:
3616679
负责人:
TING-FONG CHIN
金额:
$12.2万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1989
资助国家:
美国
项目状态:
已结题
起止时间:
1989-09-30 至 1994-09-29

项目摘要

项目成果

TING-FONG CHIN的其他基金

相似基金

相关文献

中文摘要
翻译
该资源功能的目标是开发和生产 有希望的新制剂的药学上可接受的剂型 抗艾滋病活动。一些由药物遴选委员会在 NIH将被指派作为口腔产品的开发和制造。 最初,预计第一阶段和第二阶段的批次规模较小 审判。然而,升级到大批量的III/IV阶段试验 并预计C组分布。据估计,这一点 必须准备生产数百万个口服剂量单位的项目 每年。
英文摘要
The objective of this resource function is to develop and produce pharmaceutically acceptable dosage forms of promising new agents with anti-AIDS activity. Some agents selected by a Drug Selection Committee at NIH will be assigned for development and manufacture as oral products. Initially, the batch sizes are expected to be small for Phase I and II trials. However, escalation to large batch sizes for Phase III/IV trials and Group C distribution is anticipated. It is estimated that this project must be prepared to produce several million oral dosage units each year.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
DEVELOPMENT AND MANUFACTURE OF DOSAGE FORMS OF COMPOUNDS
  • 批准号:
    2297818
  • 项目类别:
  • 资助金额:
    $16.45万
  • 财政年份:
    1989
  • 负责人:
    TING-FONG CHIN
  • 依托单位:
DEVELOPMENT AND MANUFACTURE OF DOSAGE FORMS OF COMPOUNDS
  • 批准号:
    2297811
  • 项目类别:
  • 资助金额:
    $13.56万
  • 财政年份:
    1989
  • 负责人:
    TING-FONG CHIN
  • 依托单位:
DEVELOPMENT AND MANUFACTURE OF DOSAGE FORMS OF COMPOUNDS
  • 批准号:
    2297812
  • 项目类别:
  • 资助金额:
    $14.22万
  • 财政年份:
    1989
  • 负责人:
    TING-FONG CHIN
  • 依托单位:
DEVELOP AND PRODUCE PHARMACEUTICAL DOSAGE FORMS
  • 批准号:
    3616707
  • 项目类别:
  • 资助金额:
    $46.36万
  • 财政年份:
    1989
  • 负责人:
    TING-FONG CHIN
  • 依托单位:
海外基金